15.11.2019 • NewsDede WillamsLanxess

Lanxess Sells Organometallics to PMC

Lanxess Sells Organometallics to PMC (c) Lanxess
Lanxess Sells Organometallics to PMC (c) Lanxess

German specialty chemicals company Lanxess has agreed to sell its organometallics business to US chemicals firm PMC Group. Financial terms were not disclosed.

PMC’s European subsidiary will acquire the business, which includes Lanxess’s global organotin catalyst, organotin specialties and intermediates product lines. The deal also includes a toll manufacturing agreement under which Lanxess will continue to manufacture certain products for PMC at its plant in Bergkamen, Germany, after the sale has concluded.

The transaction is scheduled to close by the end of the year, subject to customary conditions.

The acquisition is the second for PMC this year and follows the purchase of Solvay’s hydrocolloid product line in January through wholly owned French subsidiary PMC Ouvrie.  The products are sold to the home and personal care, industrial and coatings markets.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.